Literature DB >> 14507864

Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages.

Matthew J Burton1, Martin J Holland, Nkoyo Faal, Esther A N Aryee, Neal D E Alexander, Momodou Bah, Hannah Faal, Sheila K West, Allen Foster, Gordon J Johnson, David C W Mabey, Robin L Bailey.   

Abstract

PURPOSE: Trachoma is the leading cause of infectious blindness worldwide. Control strategies target antibiotic therapy to individuals likely to be infected with Chlamydia trachomatis on the basis of clinical signs. However, many studies have found chlamydial infection in the absence of clinical disease. It has been unclear whether such individuals represent a significant reservoir of infection. In the current study, a quantitative polymerase chain reaction (PCR) assay was used to investigate the distribution and determinants of chlamydial infection load in an endemic community, and the findings were used to evaluate the potential effectiveness of different control strategies.
METHODS: Members of a trachoma-endemic community (n = 1319) in a rural area of The Gambia were examined for signs of disease, and tarsal conjunctival swab samples were collected. C. trachomatis was initially detected by qualitative PCR. The load of infection was then estimated by real-time quantitative PCR.
RESULTS: Chlamydial infection was detected in 7.2% of the population. The distribution of infection load was skewed, with a few individuals having high loads. Only 24% of infected individuals had signs of active trachoma. Infection loads were higher in those with clinically active disease and were highest among those with severe inflammatory trachoma. High infection loads were associated with having no accessible latrine and living with a person with active disease.
CONCLUSIONS: In this low-prevalence setting, infected individuals without signs of active trachoma constitute a significant reservoir of infection. Treatment of a defined unit of people who live with someone with clinically active trachoma would effectively target antibiotic treatment to infected people without signs of disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14507864     DOI: 10.1167/iovs.03-0107

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  65 in total

1.  What's new in azithromyin?

Authors:  Anthony Solomon; Matthew Burton
Journal:  Community Eye Health       Date:  2004-12

2.  Trachoma control in two Central Australian Aboriginal communities: a case study.

Authors:  Van C Lansingh; Bickol N Mukesh; Jill E Keeffe; Hugh R Taylor
Journal:  Int Ophthalmol       Date:  2010-04-01       Impact factor: 2.031

3.  Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020?

Authors:  Emma M Harding-Esch; Tansy Edwards; Ansumana Sillah; Isatou Sarr; Chrissy H Roberts; Paul Snell; Esther Aryee; Sandra Molina; Martin J Holland; David C W Mabey; Robin L Bailey
Journal:  PLoS Negl Trop Dis       Date:  2009-12-22

Review 4.  Diagnosis and assessment of trachoma.

Authors:  Anthony W Solomon; Rosanna W Peeling; Allen Foster; David C W Mabey
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

5.  Where do we go from here? Prevalence of trachoma three years after stopping mass distribution of antibiotics in the regions of Kayes and Koulikoro, Mali.

Authors:  Sanoussi Bamani; Jonathan D King; Mamadou Dembele; Famolo Coulibaly; Dieudonne Sankara; Yaya Kamissoko; Jim Ting; Lisa A Rotondo; Paul M Emerson
Journal:  PLoS Negl Trop Dis       Date:  2010-07-06

6.  Elimination of active trachoma after two topical mass treatments with azithromycin 1.5% eye drops.

Authors:  Abdou Amza; Pablo Goldschmidt; Ellen Einterz; Pierre Huguet; Celine Olmiere; Philippe Bensaid; Lucienne Bella-Assumpta
Journal:  PLoS Negl Trop Dis       Date:  2010-11-23

7.  Targeting antibiotics to households for trachoma control.

Authors:  Isobel M Blake; Matthew J Burton; Anthony W Solomon; Sheila K West; María-Gloria Basáñez; Manoj Gambhir; Robin L Bailey; David C W Mabey; Nicholas C Grassly
Journal:  PLoS Negl Trop Dis       Date:  2010-11-02

8.  Profound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communities.

Authors:  Matthew J Burton; Martin J Holland; Pateh Makalo; Esther A N Aryee; Ansumana Sillah; Sandra Cohuet; Angels Natividad; Neal D E Alexander; David C W Mabey; Robin L Bailey
Journal:  PLoS Negl Trop Dis       Date:  2010-10-05

9.  Active trachoma among children in Mali: Clustering and environmental risk factors.

Authors:  Mathieu Hägi; Jean-François Schémann; Frédéric Mauny; Germain Momo; Doulaye Sacko; Lamine Traoré; Denis Malvy; Jean-François Viel
Journal:  PLoS Negl Trop Dis       Date:  2010-01-19

Review 10.  The global burden of trachoma: a review.

Authors:  Matthew J Burton; David C W Mabey
Journal:  PLoS Negl Trop Dis       Date:  2009-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.